Zujun Que

713 total citations
35 papers, 551 citations indexed

About

Zujun Que is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zujun Que has authored 35 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Zujun Que's work include Cancer Cells and Metastasis (11 papers), Immune cells in cancer (6 papers) and Cancer Research and Treatments (5 papers). Zujun Que is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Immune cells in cancer (6 papers) and Cancer Research and Treatments (5 papers). Zujun Que collaborates with scholars based in China, United States and Australia. Zujun Que's co-authors include Jianhui Tian, Jianwen Liu, Bin Luo, Yuanhong Zheng, Zhiyi Zhou, Hegen Li, Changsheng Dong, Vanminh Le, Lingling Zhang and Shengchao Lin and has published in prestigious journals such as Scientific Reports, Science Advances and Journal of Ethnopharmacology.

In The Last Decade

Zujun Que

31 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zujun Que China 16 251 155 134 88 75 35 551
Yuhong Sun China 13 238 0.9× 124 0.8× 80 0.6× 80 0.9× 80 1.1× 25 576
Yanna Jiao China 10 256 1.0× 105 0.7× 107 0.8× 103 1.2× 64 0.9× 21 510
Mengyao Sun China 15 414 1.6× 97 0.6× 125 0.9× 76 0.9× 82 1.1× 36 725
Yuanhong Zheng China 13 235 0.9× 100 0.6× 140 1.0× 69 0.8× 107 1.4× 13 487
Maryam Nakhjavani Australia 15 353 1.4× 95 0.6× 114 0.9× 44 0.5× 54 0.7× 37 605
Fengjun Cao China 16 355 1.4× 127 0.8× 136 1.0× 63 0.7× 70 0.9× 23 589
Itishree Kaushik United States 10 435 1.7× 212 1.4× 156 1.2× 121 1.4× 90 1.2× 12 756
Shravanti Mukherjee India 15 513 2.0× 277 1.8× 198 1.5× 134 1.5× 47 0.6× 25 880
Shengchao Lin China 11 296 1.2× 74 0.5× 201 1.5× 62 0.7× 69 0.9× 12 497
Yougen Wu China 12 302 1.2× 120 0.8× 133 1.0× 43 0.5× 54 0.7× 24 573

Countries citing papers authored by Zujun Que

Since Specialization
Citations

This map shows the geographic impact of Zujun Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zujun Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zujun Que more than expected).

Fields of papers citing papers by Zujun Que

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zujun Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zujun Que. The network helps show where Zujun Que may publish in the future.

Co-authorship network of co-authors of Zujun Que

This figure shows the co-authorship network connecting the top 25 collaborators of Zujun Que. A scholar is included among the top collaborators of Zujun Que based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zujun Que. Zujun Que is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Long, Yanhong Wang, Zujun Que, et al.. (2025). TSZAF monomer combination downregulates the Wnt/β-catenin signaling pathway and inhibits neutrophil recruitment to prevent lung cancer metastasis. Chinese Journal of Natural Medicines. 23(9). 1069–1079. 1 indexed citations
3.
Zhang, Zhipeng, Xiaoping Lu, Jianhui Tian, et al.. (2025). c-MET Inhibition Reverses the Osimertinib Resistance in Lung Circulating Tumor Cell Clusters and Suppresses Metastasis. Biological Procedures Online. 27(1). 32–32.
4.
Liu, Shihui, et al.. (2024). Lung metastases formed by disseminated tumor cells exhibit different proliferation states. Acta Biochimica et Biophysica Sinica. 57(2). 321–324. 1 indexed citations
5.
Wang, Mengfei, Meng Xu, Ziqi Chen, et al.. (2024). Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis. International Journal of Biological Sciences. 20(7). 2454–2475. 6 indexed citations
6.
Zhang, Zhipeng, Yao Wang, Xiaoyu Yang, et al.. (2024). Maimendong decoction inhibits lung cancer metastasis by increasing the proportion and killing activity of NK cells. Journal of Ethnopharmacology. 338(Pt 3). 119127–119127. 2 indexed citations
7.
Yang, Yun, Li Zhu, Yu Pan, et al.. (2023). Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway. Acta Biochimica et Biophysica Sinica. 55(11). 1851–1854. 1 indexed citations
8.
Tian, Jianhui, et al.. (2023). Jinfukang inhibits lung cancer metastasis by regulating T cell receptors. Journal of Ethnopharmacology. 318(Pt A). 116885–116885. 8 indexed citations
9.
Luo, Bin, Zujun Que, Dan Qi, et al.. (2023). Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer. Biological Procedures Online. 25(1). 29–29. 16 indexed citations
10.
Que, Zujun, Yu Pan, Dan Qi, et al.. (2023). Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation. International Journal of Biological Sciences. 19(16). 5204–5217. 18 indexed citations
11.
Zhang, Guangtao, Zhaoyan Li, Jiahuan Dong, et al.. (2022). Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway. BMC Complementary Medicine and Therapies. 22(1). 10–10. 25 indexed citations
13.
Que, Zujun & Jianhui Tian. (2022). New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells. Cancer Cell International. 22(1). 356–356. 4 indexed citations
14.
Que, Zujun, Zhiyi Zhou, Yu Pan, et al.. (2021). Jinfukang inhibits lung cancer metastasis by upregulating CX3CL1 to recruit NK cells to kill CTCs. Journal of Ethnopharmacology. 275. 114175–114175. 22 indexed citations
15.
Que, Zujun, et al.. (2021). Paclitaxel-loaded and folic acid-modified PLGA nanomedicine with glutathione response for the treatment of lung cancer. Acta Biochimica et Biophysica Sinica. 53(8). 1027–1036. 18 indexed citations
16.
Que, Zujun, Bin Luo, Yi Jiang, et al.. (2020). Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer. Journal of Ethnopharmacology. 256. 112802–112802. 12 indexed citations
17.
Que, Zujun, Bin Luo, Zhiyi Zhou, et al.. (2019). Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo. Cancer Cell International. 19(1). 21–21. 62 indexed citations
18.
Que, Zujun, Zhiyi Zhou, Bin Luo, et al.. (2019). Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells. BMC Complementary and Alternative Medicine. 19(1). 204–204. 23 indexed citations
19.
Que, Zujun, et al.. (2018). Jinfukang induced senescence of circulating tumor cells in lung cancer by p16/RB signal pathway. Tumori. 38(3). 215–221. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026